Toe Walker Gait Trial
- Conditions
- Gait
- Registration Number
- NCT01208142
- Lead Sponsor
- Dynasplint Systems, Inc.
- Brief Summary
The purpose of this study is to examine the change in ankle plantar flexion while walking, following treatment with the Ankle Dorsiflexion Dynasplint (AFD) for children diagnosed as Toe Walkers.
For twelve weeks, patients will either receive the standard treatment or the same standard treatment and the Dynaslint worn at night.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 10
- Toe Walking secondary to CP
- Idiopathic TW
- Inability to ambulate with initial heel-contact
- Inability to bear weight and stand flat-footed for over one minute
- Inability to stand or hop on one foot (symptomatic) for more than one minute
- Acid Maltase Deficiency Myopathy
- Acute Paralytic Poliomyelitis
- Spinal Muscular Atrophy-all types
- Stroke, ischemic or hemorrhagic, all types
- Multiple Sclerosis
- Traumatic Brain Injury (including Shaken Baby Syndrome)
- Unilateral ROM deficits in Knee or Hip
- Previous Achilles Tendon lengthening surgery
- Hemiplegic Cerebral Palsy
- Muscular Dystrophy-all types
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in plantar flexion while ambulating 12 weeks The primary endpoint or dependent variable of this study will be the change in excessive plantar flexion while ambulating. A repeated measures analysis of variance (ANOVA) will be performed to measure kinematic change in gait patterns calculated with an ambulation laboratory test.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
The Ohio State University Medical Center
🇺🇸Columbus, Ohio, United States
Texas Tech University Health Sciences Center
🇺🇸Lubbock, Texas, United States
The Ohio State University Medical Center🇺🇸Columbus, Ohio, United States